BioMeBar™ — Gut Intelligence Report

Overview

Gut Intelligence Summary

Your Digestive Clarity and Motility Rhythm are both performing excellently, with scores of 90 and 89 respectively, indicating smooth digestion and movement through your gut. Your Fermentation Efficiency is outstanding at 100 — a testament to your consistently strong dietary habits. Your very low Dysbiosis Risk of 7 reflects a healthy microbiome balance, which is a significant foundation to build on. While your Glycemic Stability is currently at 10, this presents a targeted opportunity for improvement that can unlock further benefits across your overall gut health and energy.

Strengths

Fermentation Efficiency — 100

Digestive Clarity — 90

Motility Rhythm — 89

Gut Resilience — 80

Nutrient Utilization — 80

Diversity Surrogate — 80

Immune Resilience — 71

Metabolic Efficiency — 70

Dysbiosis Risk — 7 ↓

Developing

Microbial Diversity — 65

Certain B vitamin levels (borderline)

Vitamin D (sufficient, not optimal)

Mild stool panel signals

Focus Areas

Glycemic Stability — 10

Glycaemic wellness indicators (borderline)

Systemic inflammatory markers (elevated)

Finding 01

Your Digestive Clarity score of 90 indicates your digestive system is functioning exceptionally well, allowing effective breakdown and absorption of nutrients with minimal friction.

Finding 02

With a Fermentation Efficiency score of 100, your gut is perfectly processing fibres and complex carbohydrates, producing beneficial compounds and maintaining an ideal fermentation environment.

Finding 03

Your Dysbiosis Risk of 7% reflects an impressively balanced microbiome — confirmed by excellent intestinal wellness markers and the complete absence of pathogenic signals in the stool panel.

Finding 04

Your Glycemic Stability score of 10 — supported by borderline glycaemic indicators and elevated systemic inflammatory markers — indicates an inflammation–glycaemic axis that needs targeted intervention.

Metric Detail

Gut Intelligence Scorecard

11 functional dimensions · Advanced Gut Report

Core Gut Function

Fermentation Efficiency

How effectively gut bacteria break down fibre and carbohydrates into beneficial compounds.

Needs FocusGood

100

Digestive Clarity

Smoothness and completeness of the digestive process from intake to elimination.

Needs FocusGood

Motility Rhythm

Regularity and quality of gut transit — from stool consistency to bowel movement frequency.

Needs FocusGood

Nutrient Utilization

Efficiency of the gut in absorbing and using macro- and micronutrients from food.

Needs FocusGood

Resilience & Diversity

Gut Resilience

The gut ecosystem's ability to recover from stressors — dietary, environmental, or lifestyle.

Needs FocusGood

Diversity Surrogate

Estimated functional breadth of the microbiome — how many distinct ecological niches are populated.

Needs FocusGood

Microbial Diversity

Modelled richness and evenness of the microbial community inferred from dietary and wellness patterns.

Needs FocusGood

Dysbiosis Risk ↓ lower is better

Mathematical likelihood of a significant microbiome imbalance or pathogenic overgrowth.

Risk →→ Resilience

Metabolic & Immune

Immune Resilience

The gut's contribution to immune regulation and defence against inflammatory triggers.

Needs FocusGood

Metabolic Efficiency

How effectively the gut–microbiome system supports energy metabolism, glucose handling, and lipid balance.

Needs FocusGood

Glycemic Stability

The gut microbiome's contribution to maintaining stable blood glucose levels and insulin sensitivity.

Needs FocusGood

Deep Dive

Functional Block Analysis

Core · Resilience · Metabolic · Interpretation & takeaways

Core Gut Function

Fermentation Efficiency

Optimal breakdown of food, producing beneficial compounds.

Needs FocusGood

100

Motility Rhythm

Regularity of bowel movement and transit time.

Needs FocusGood

Nutrient Utilization

Absorption efficiency of key macro- and micronutrients.

Needs FocusGood

Digestive Clarity

Overall clarity and smoothness of the digestive process.

Needs FocusGood

Your Fermentation Efficiency is outstanding at 100, indicating that your gut is effectively breaking down food and producing beneficial compounds — a direct reflection of your daily fermented food intake and high-fibre diet.

With a Motility Rhythm score of 89, your digestive system is functioning smoothly, promoting regular bowel movements and optimal gut transit — confirmed by stool consistency signals in the wellness panel.

Your Nutrient Utilization score of 80 reflects that your body is efficiently absorbing the nutrients it needs — stool panel markers confirm no significant malabsorption.

A strong Digestive Clarity score of 90 suggests you are experiencing clear and effective digestion, contributing to overall comfort and absence of major gastrointestinal symptoms.

Resilience & Diversity Block

Gut Resilience

Ecosystem recovery capacity from stressors.

Needs FocusGood

Immune Resilience

Gut-immune axis strength and inflammatory regulation.

Needs FocusGood

Microbial Diversity

Richness and evenness of the modelled microbial community.

Needs FocusGood

Metabolic Block · Advanced Add-On

Glycemic Stability

Microbiome contribution to blood glucose regulation and insulin sensitivity.

Needs FocusGood

Dysbiosis Risk ↓ lower is better

Likelihood of significant microbiome imbalance.

Risk →→ Resilience

Metabolic Efficiency

Gut-mediated energy metabolism and lipid handling.

Needs FocusGood

Your scores reflect a strong foundation for gut health, particularly with a remarkable Fermentation Efficiency of 100, indicating optimal fermentation and beneficial postbiotic production.

Your Dysbiosis Risk is impressively low at 7, suggesting a healthy balance of gut microbiota — confirmed by excellent intestinal wellness markers and no pathogenic organisms detected in the stool panel.

Your Glycemic Stability score of 10 indicates a significant area for improvement. Borderline glycaemic indicators in the wellness panel are concordant signals requiring targeted dietary attention.

Addressing Glycemic Stability can unlock further benefits — enhancing your Metabolic Efficiency of 70 and strengthening your Immune Resilience score, particularly given the elevated systemic inflammatory markers in the wellness panel.

Clinical Pattern

Key Imbalances Identified

Glycemic Stability — Critical Concern

Certain metabolic wellness indicators sit in a borderline range, supported by glucose regulation signals within the panel. The Glycemic Stability score of 10 reflects the gut microbiome's current limited contribution to blood glucose regulation. The key driver is likely a relative reduction in Bifidobacterium species — which play a direct role in GLP-1 stimulation and short-chain fatty acid production for glycaemic control. Combining this with elevated systemic inflammatory markers, an inflammation–glycaemic coupling is present that warrants immediate dietary intervention.

Developing Microbial Diversity

Your Microbial Diversity score of 65 indicates a moderately developing microbiome ecosystem. While your dietary inputs are excellent (daily fibre, daily fermented foods, daily fruits and vegetables), the wellness panel concordance — particularly borderline B vitamin levels and the elevated inflammatory signal — suggests that certain key families, particularly Akkermansiaceae and Bifidobacteriaceae, may not be fully optimised. Expanding dietary variety with targeted prebiotic substrates and diverse plant polyphenols can meaningfully shift this score.

Maintaining Strong Fermentation Efficiency

Your Fermentation Efficiency of 100 is a critical asset to protect. This exceptional score is driven by your daily fermented food intake, high fibre consumption, and excellent stool fermentation markers. Stool consistency and the absence of malabsorption signals confirm complete carbohydrate fermentation. The risk is that any reduction in dietary adherence — particularly around fermented foods and fibre — could erode this benchmark. The protocol below is designed to protect this strength while improving the glycaemic and diversity axes.

Microbiome Intelligence

Microbiome Family Composition Analysis

Activity Index relative to South Indian dietary cohort reference range · Inferred from wellness panel + dietary survey signals

Microbiome Family	Activity Index	Direction	Prior Wt.	Inference Basis
Lactobacillaceae Lactobacillus spp.	74	Within Range	0.81	Daily fermented food intake is the primary driver. Fermentation Efficiency of 100 is a strong concordant signal. Stool panel fermentation markers confirm active lactic acid fermentation. Soft, well-formed stool pattern is fully consistent.
Bifidobacteriaceae Bifidobacterium spp.	58	Below Optimal	0.76	Borderline glycaemic wellness indicators are strong concordant signals — Bifidobacterium directly mediates GLP-1 and short-chain fatty acid production. Borderline B vitamin levels provide secondary signal. Sugar cravings (score 3) are behaviourally consistent.
Ruminococcaceae Faecalibacterium, Ruminococcus	73	Within Range	0.69	Daily high-fibre intake and daily fruits/vegetables provide adequate resistant starch and inulin substrate. Good stool consistency and absent stool mucus support functional butyrate production from this family.
Lachnospiraceae Roseburia, Blautia, Butyrivibrio	68	Within Range	0.64	Moderate inference from dietary diversity and good fermentation metrics. Borderline iron-binding wellness markers provide a secondary signal for the iron-absorption pathway mediated by this family. Within cohort reference range.
Akkermansiaceae Akkermansia muciniphila	49	Below Optimal	0.82	Elevated systemic inflammatory markers are the primary concordant signal — Akkermansia is a key mucosal integrity organism whose depletion is consistently associated with low-grade systemic inflammation. Mild stool panel inflammatory signals provide secondary confirmation.
Prevotellaceae Prevotella copri complex	57	Within Range	0.67	South Indian dietary phenotype with high rice, lentils, and fermented food intake is a known driver of moderate Prevotella presence. Not dominant — excellent intestinal wellness markers suggest a balanced level without dysbiotic risk.
Bacteroidaceae Bacteroides fragilis group	66	Within Range	0.55	Primarily inferred from dietary phenotype prior. Plant-forward, high-fibre diet supports moderate Bacteroidetes activity. Excellent intestinal inflammatory markers in the wellness panel indirectly confirm a stable commensal Bacteroidaceae population.
Clostridiaceae (pathogenic) Clostridium sensu stricto	14	Low (Favourable)	0.86	No pathogens detected in stool (cysts, helminths, protozoa all absent). Dysbiosis Risk 7% is extremely low. No recent antibiotic use — a key protective factor. Intestinal wellness markers confirm no pathogenic Clostridial presence.

Reference range based on South Indian dietary cohort priors (Phase I model). Activity Index (0–100) represents inferred relative functional activity, not absolute abundance. Low score for Clostridiaceae (pathogenic) is favourable. Individual variation applies.

Pathway Analysis

Functional Metabolic Pathway Assessment

Inferred from microbiome family activity × wellness panel concordance

Short-Chain Fatty Acid Biosynthesis

Pathway: Butyrate / Propionate Production

72%

◆ Within Reference

Primary drivers: ↑Ruminococcaceae (73), ↑Lachnospiraceae (68) · High daily fibre substrate

Intestinal Mucus Layer Integrity

Pathway: Mucin Glycan Metabolism / Mucosal Barrier

51%

▼ Suboptimal

Primary drivers: ↓Akkermansiaceae (49) · Elevated systemic inflammatory markers — strong concordant signal

Glycemic Regulation Axis

Pathway: GLP-1 Stimulation / Insulin Sensitivity

18%

▼ Compromised

Primary drivers: ↓Bifidobacteriaceae (58) · Borderline glycaemic wellness indicators concordant

Tryptophan / Serotonin Biosynthesis

Pathway: Indole / Serotonin Precursor Synthesis

70%

◆ Active

Primary drivers: ↑Lactobacillaceae (74) · Daily fruit/vegetable intake provides tryptophan substrate

Immune Pathway Priming (TLR Axis)

Pathway: Pattern Recognition / Epithelial Signalling

47%

▼ Below Optimal

Primary drivers: ↓Akkermansiaceae · Elevated inflammatory markers signal dysregulated immune priming · Frequent infection pattern (score 5)

Secondary Bile Acid Biotransformation

Pathway: BSH Activity / Deoxycholate Production

68%

◆ Adequate

Primary drivers: Lactobacillaceae (74) + Prevotellaceae balance · Good bile acid cycling supported by fermented food intake

Microbial B Vitamin Synthesis

Pathway: De Novo Folate / Cobalamin Synthesis

57%

▼ Developing

Primary drivers: ↓Bifidobacteriaceae · Concordant with borderline B vitamin levels in the wellness panel

Hydrogen / Methane Fermentation Balance

Pathway: Cross-Feeding / Methanogenic Equilibrium

82%

◆ Excellent

Primary drivers: Fermentation Efficiency 100 · Optimal stool fermentation pH · Low gas odour (score 1) and low bloating (score 1) concordant

Pathway activity represents inferred functional output at the ecosystem level. Values are derived from the concordance of microbiome family activity indices with wellness panel signals. Not a single-enzyme measure.

Phenotype Classification

Dietary Phenotype & Microbiome Prior

South Indian cohort reference · Phase I model

Assigned Phenotype Cluster

South Indian — Lacto-Vegetarian, High Fermented

High complex carbohydrate load (rice, millet, lentils). Very high fermented food intake (idli, dosa, yogurt, kanji). Daily fruits and vegetables. Well-hydrated (2–3L daily). Limited tea/coffee exposure. Occasional fried foods (2–3×/week). Rarely processed foods.

High Fermented Food Intake Daily High Fibre Excellent Hydration No Tea/Coffee Load Moderate Fried Food Borderline Sugar Intake

Microbiome Prior Characteristics

Lactobacillus-Supported, Bifido-Developing Profile

This dietary cluster is associated with strong Lactobacillus activity driven by fermented food habits — a distinguishing feature of South Indian diets. However, the borderline glycaemic and elevated inflammatory wellness signals suggest that Bifidobacterium and Akkermansia families need targeted support despite the otherwise excellent dietary inputs.

Strong Lactobacillus Prior Good Ruminococcaceae Prior Moderate Prevotella Prior Reduced Bifido Signal Reduced Akkermansia Signal

Dietary Survey Signal Inputs Used In This Report

✓ Fermented food frequency — Daily

✓ High-fibre intake — Daily

✓ Fruits & vegetables — Daily

✓ Processed food exposure — Rarely

✓ Fried food frequency — 2–3×/week

✓ Sugar frequency — 2–3×/week

✓ Hydration level — 2–3L daily

✓ Tea/coffee — Never

✓ Antibiotic use (recent) — None

✓ Probiotic / prebiotic — Not supplementing

✓ Stool type (normal) — Soft, well-formed

✓ Physical activity score — Moderate (2)

✓ Stress score — Moderate (2)

✓ Sleep quality — Good (1)

✓ Low energy symptom — Score 4 (notable)

✓ Infection frequency — Score 5 (frequent)

✓ Sugar cravings — Score 3 (moderate)

Clinical Guidance

Priority Functional Intervention Targets

Ranked by multi-signal concordance strength and functional impact

Glycaemic Stability + Inflammation–Glycaemic Axis

Borderline glycaemic indicators + Elevated inflammatory markers + ↓Bifidobacteriaceae (58)

This is the highest-priority functional deficit in this profile. The convergence of borderline glycaemic wellness indicators and substantially elevated systemic inflammatory markers creates a compounded inflammation–glycaemic signal. Reduced Bifidobacterium activity — inferred at 58 activity index — directly impacts GLP-1 stimulation, short-chain fatty acid production, and downstream insulin sensitivity. The sugar craving score of 3 is a behavioural concordant signal. Targeted dietary interventions to increase prebiotic inulin-type fructans (chicory root, Jerusalem artichoke, garlic), combined with resistant starch sources, are the primary lever to rebuild this axis.

Bifidobacteriaceae ↓Glycaemic Axis ↓Inflammatory Signal Elevated

Evidence Density

0.89

Mucosal Barrier Restoration + Anti-Inflammatory Support

Elevated inflammatory markers + Mild stool panel signals + ↓Akkermansiaceae (49) + Immune Resilience 71

The elevated systemic inflammatory markers are a clinically significant finding in a 21-year-old female with an otherwise excellent dietary profile. The most likely microbiome-level explanation is reduced Akkermansia muciniphila activity (inferred at 49 — below optimal), which directly governs mucin layer renewal, tight junction protein expression, and the TLR-mediated immune calibration axis. Mild stool panel signals provide secondary inflammatory confirmation. Despite excellent intestinal wellness markers — which rule out local intestinal inflammation — the systemic inflammatory signal suggests low-grade systemic immune activation. Polyphenol-rich foods (pomegranate, cranberry, dark berries), omega-3 sources (flaxseed, walnuts), and a reduction in fried food frequency are the primary dietary interventions.

Akkermansiaceae ↓Inflammatory Signal HighMucosal Pathway ↓

Evidence Density

0.83

B Vitamin Optimisation + Microbial Diversity Enhancement

Borderline B vitamin levels + Microbial Diversity 65 + ↓Bifidobacteriaceae · Infection frequency score 5

Certain B vitamin levels, while technically within detectable range, fall below the functional optimum recommended for young women. The concordance with reduced Bifidobacterium activity — which contributes to microbial B vitamin synthesis — makes this a dual dietary and microbiome target. Microbial Diversity at 65 is developing; the primary lever is dietary diversity expansion. Rotating fermented food types (kefir, diverse yogurt strains, tempeh, miso), introducing novel plant food families weekly, and adding a broad-spectrum prebiotic substrate (diverse legumes, under-ripe banana, cooked-and-cooled rice) can meaningfully shift both scores. The frequent infection pattern (score 5) is likely connected to this immune-diversity axis.

B Vitamin BorderlineMicrobial Diversity 65Bifidobacteriaceae ↓

Evidence Density

0.74

Your Roadmap

Personalised Protocol

Three-phase progressive gut restoration plan

Phase 1

Calm & Stabilise

Weeks 1–4

Key Superfoods

→ Leafy greens

→ Avocado

→ Walnuts, flaxseed

Focus on reducing the inflammatory load — introduce polyphenol-rich anti-inflammatory foods daily. Prioritise omega-3 sources to begin modulating the systemic inflammatory axis. You may feel more balanced energy levels and improved digestion within 2–3 weeks.

Phase 2

Rebuild & Sync

Weeks 5–8

Key Superfoods

→ Diverse yogurt strains

→ Kimchi, sauerkraut

→ Chicory, garlic, leek

Expand fermented food diversity to support Bifidobacterium and Akkermansia recovery. Introduce targeted prebiotic substrates (inulin-type fructans) to directly address the glycaemic–microbiome axis. You might notice enhanced nutrient absorption and improved energy within this phase.

Phase 3

Diversify & Strengthen

Weeks 9–12

Key Superfoods

→ 30+ plants/week

→ Whole grains, millet, oats

→ Diverse legumes

Consolidate diversity gains with a structured 30-plant-per-week dietary rotation. Target glycaemic stability through resistant starch loading (cooked-and-cooled rice, under-ripe banana). You could experience increased vitality, reduced sugar cravings, and a stronger immune response.

Methodology

The Science Behind This Report

BioMeBar's philosophy centres on viewing the gut as a functional system rather than just a list of microbes. We focus on key processes like digestion, nutrient absorption, maintaining a healthy barrier, and managing inflammation — all of which are interconnected with the gut-brain axis. Our approach emphasises the importance of functional signals and postbiotics, offering personalised phased support that prioritises repair before disease sets in.

This Advanced Gut Report combines two layers of intelligence: the Gut Intelligence Score system, which distils dietary survey and wellness panel signals into eleven functional dimensions, and the Family-Level Microbiome Composition Analysis, which uses a Bayesian inference framework to estimate functional activity across eight key microbiome families. The inference engine cross-references dietary phenotype priors (calibrated on the South Indian dietary cohort), direct wellness panel signals, and symptom concordance to derive the posterior activity estimates shown in this report.

This holistic perspective allows us to empower individuals to achieve better gut health and overall well-being — not by sequencing individual microbes, but by understanding the functional ecosystem they form together.

Your gut health journey is deeply personal, and this report has been designed to give you the clearest possible picture of what's happening inside — and what we can do about it. Every score, every recommendation, and every phase has been crafted with your specific pattern in mind. You are not a generic case, and neither is your protocol.

What stands out in your profile is the remarkable contrast between your exceptional gut function scores (Fermentation Efficiency 100, Digestive Clarity 90, Motility Rhythm 89) and the under-the-surface inflammatory and glycaemic signals identified in your wellness panel. Your gut is working beautifully — and with the right targeted interventions, you have an excellent foundation to resolve these upstream signals before they progress. This is exactly the right time to act.

BioMeBar™ Science & Nutrition Team

Personalised Gut Intelligence · thebiomebar.com

Score Summary

Fermentation Efficiency100%

Digestive Clarity90%

Motility Rhythm89%

Gut Resilience80%

Nutrient Utilization80%

Diversity Surrogate80%

Immune Resilience71%

Metabolic Efficiency70%

Microbial Diversity65%

Dysbiosis Risk ↓7%

Glycemic Stability10%

—

Legal & Medical

Disclosures & Disclaimer

Company & Independence Disclosure

BioMeBar™ is an independent wellness and biotechnology company that provides gut health insights, postbiotic analysis, and personalised probiotic recommendations. BioMeBar is not operated by, owned by, or affiliated with any diagnostic laboratory. Laboratory and wellness panel processing services, where applicable, are performed by independent, third-party, certified service providers solely for the purpose of sample processing and generation of raw data. BioMeBar's role is limited to: interpretation of data for wellness insights; postbiotic and gut-health–focused analysis; and providing non-diagnostic, educational, and personalised probiotic and lifestyle recommendations.

Wellness Indicators Only

All reports, insights, interpretations, recommendations, and content provided by BioMeBar (collectively, the “Report”) are intended strictly for informational, educational, and wellness purposes only. The Report is not a diagnostic report, is not intended to diagnose, treat, cure, or prevent any disease, and does not constitute medical advice. This Report is classified as Wellness Indicators Only and must not be used for clinical decision-making. The scores, microbiome family estimates, pathway assessments, and all other outputs in this Report are wellness-oriented functional estimates derived from dietary survey data and stool panel signals — they are not equivalent to clinical laboratory diagnosis or clinical microbiome sequencing.

Professional Consultation Requirement

Any interpretation of the Report or any preventive or therapeutic action taken based on it must be undertaken only in consultation with a qualified healthcare professional, including licensed physicians, clinicians, dietitians, nutritionists, or other certified healthcare practitioners. BioMeBar does not recommend self-diagnosis or self-medication. BioMeBar shall not be held responsible or liable for: actions taken without consulting a Professional Practitioner; misinterpretation of the Report; or any adverse effects, health outcomes, losses, or damages resulting from reliance on the Report.

Scope & Limitations

The insights provided are limited to currently available scientific evidence related to gut microbiome composition, postbiotic markers and metabolic signals, and general gut-health–related patterns. Microbiome and postbiotic science is an evolving field — not all microbial groups, metabolites, or associations are known, validated, or clinically understood. This Report does not cover all clinically relevant microbes or conditions, and reflects interpretations based on present scientific consensus, which may change over time. Microbiome family activity values are inferred functional estimates, not direct measurements of microbial abundance; individual variation applies.

No Medical History Consideration

Unless expressly stated otherwise, the Report assumes you are in a general state of good health and does not account for your complete medical history, existing conditions, genetic factors, medications, supplements, or treatments (past or present). You must consult a Professional Practitioner for individualised medical or therapeutic advice. If any wellness panel value identified in this report falls outside normal reference ranges, you must discuss this with your physician — this Report does not provide clinical interpretation of laboratory values.

Personalised Probiotic Disclaimer

Personalised probiotic or synbiotic recommendations are based on gut-health insights and wellness-oriented interpretation of data. They are not pharmaceutical products and are not intended to replace prescribed medications or medical treatment. Individual responses to probiotics vary. BioMeBar does not guarantee specific health outcomes.

Third-Party Service & Data Disclaimer

BioMeBar does not control sample collection procedures, panel processing methodologies, or quality control processes performed by third-party service providers. BioMeBar shall not be liable for errors, omissions, or inaccuracies originating from sample degradation, contamination, or delays caused by third-party service providers.

No Warranties & Limitation of Liability

BioMeBar makes no warranties, express or implied, including but not limited to warranties of accuracy, completeness, merchantability, fitness for a particular purpose, or non-infringement. Use of BioMeBar services and Reports is entirely at your own risk. In no event shall BioMeBar be liable for any indirect, incidental, special, or consequential damages arising out of or in connection with use of this Report.

Report prepared for Sample Client — Order #XXXXXXXXX — XX May 2026 — BioMeBar™ Advanced Gut Report